Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex With Men, With or Without Use of Pre-exposure Prophylaxis.

Open forum infectious diseases·2026
Same author

Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial.

Pharmacological research·2025
Same author

Optimizing Immunization Strategies for Individuals Living with HIV: A Review of Essential Vaccines, Vaccine Coverage, and Adherence Factors.

Vaccines·2025
Same author

Vitrectomy with and without encircling band for pseudophakic retinal detachment: VIPER study report No. 4-long-term results.

The British journal of ophthalmology·2025
Same author

Transcatheter Repair Versus Surgery for Atrial Versus Ventricular Functional Mitral Regurgitation: A Post Hoc Analysis of the MATTERHORN Trial.

Circulation·2024
Same author

Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B.

Pharmaceutics·2024
Same journal

[The progress of participation research. A sociological analysis of its institutionalization].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

[The Competence Network for HIV/AIDS. Data, Samples, Facts].

Claudia Michalik1,2, Adriane Skaletz-Rorowski1, Norbert H Brockmeyer3,4

  • 1Kompetenznetz HIV/AIDS, Ruhr-Universität Bochum, Bochum, Deutschland.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|March 11, 2016
PubMed
Summary
This summary is machine-generated.

The Competence Network for HIV/AIDS (KompNet HIV/AIDS) established a robust research infrastructure, including extensive patient cohorts and biobanks. This network facilitates national and international collaboration to improve HIV/AIDS treatment and patient outcomes.

Keywords:
BiobankCompetence network for HIV/AIDSHIVHIV-cohortHIV-database

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Published on: March 3, 2017

11.2K

Related Experiment Videos

Last Updated: Mar 24, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Published on: March 3, 2017

11.2K

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Public Health

Background:

  • The Competence Network for HIV/AIDS (KompNet HIV/AIDS) was established as an interdisciplinary research association funded by the Federal Ministry of Education and Research.
  • It integrated key working groups across Germany focused on clinical and basic HIV/AIDS research.

Purpose of the Study:

  • To provide a comprehensive research infrastructure for national and international cooperation in HIV/AIDS.
  • To improve HIV infection treatment and enhance the life expectancy of HIV-infected patients by consolidating research efforts.

Main Methods:

  • KompNet HIV/AIDS comprises HIV experts, university clinics, physicians, patient representatives, and national reference centers.
  • An HIV patient cohort was established, collecting clinical, sociodemographic data, serum, and DNA samples biannually.
  • A dedicated child cohort was also established for pediatric HIV research.

Main Results:

  • A significant research infrastructure for HIV was established, accessible to scientists globally.
  • The HIV cohort includes 16,500 documented patients, with a biobank containing approximately 56,000 serum and 16,000 DNA samples.
  • The child cohort comprises 647 HIV-exposed and 230 HIV-infected children, contributing to international collaborations.

Conclusions:

  • KompNet HIV/AIDS has successfully created a vital research infrastructure for HIV, fostering both domestic and international scientific engagement.
  • The established cohorts are crucial for advancing HIV research and have become key partners in international studies.
  • Sustaining these research infrastructures without consistent public funding presents a significant ongoing challenge.